fb script Marllor Biomedical | Buy Authentic Products Online
e-Fillers Logo
Marllor Biomedical

Marllor Biomedical

Marllor Biomedical, founded in 2009 by Dr. Pasquale Motolese and Vania Bedetti, is an Italian company renowned for its innovative contributions to non-surgical aesthetic medicine. Headquartered in San Giovanni in Marignano, Italy, Marllor Biomedical specializes in the development and production of medical devices and procedures that enhance patient confidence and aesthetics. The company is best known for its groundbreaking products, such as Aqualyx, a fat-dissolving solution, and Alidya, the first injectable specifically designed to treat cellulite. These products are widely recognized for their effectiveness and have established a strong presence in over 60 countries globally. Marllor Biomedical emphasizes high standards of quality, adhering to ISO, CE, and GMP certifications. Their commitment to scientific research and innovation ensures that they remain at the forefront of the aesthetic medicine industry. The company's extensive product portfolio also includes Lipoinject and Mesoinject, further showcasing their dedication to providing comprehensive aesthetic solutions​.

Aqualyx®

Aqualyx® is a revolutionary fat dissolving injection designed to target and reduce localized fat deposits in areas such as the chin, stomach, thighs, and hips. Utilizing a unique deoxycholate-based solution, Aqualyx® breaks down fat cells, which are then naturally eliminated by the body. This non-surgical treatment provides a safe and effective alternative to liposuction, offering visible results without the need for invasive procedures. Ideal for contouring and reshaping the body, Aqualyx® is suitable for patients looking to achieve a slimmer, more defined appearance. Experience the benefits of Aqualyx® and achieve your body goals with this innovative fat reduction solution.

ALIDYA

Alidya® is a pioneering brand specializing in injectable treatments designed to combat and prevent cellulite. Developed by Professor Pasquale Motolese and produced by Marllor Biomedical, Alidya® works by targeting the underlying causes of cellulite, including poor microcirculation and toxin build-up in adipose tissue. The formula consists of amino acids and other compounds that promote fat dissolution, improve lymphatic drainage, and enhance skin firmness and elasticity. Alidya® treatments are administered through a series of intradermal injections, typically over several sessions, to achieve optimal results. This non-invasive mesotherapy solution is suitable for various areas affected by cellulite, such as the thighs, buttocks, and abdomen, providing patients with smoother, more toned skin and renewed confidence​

Marllor Biomedical Introduction

The Italian company Marllor Biomedical designs, develops and markets medical device technology and provides a technical contribution to the scientific leading non-surgical procedures in medicine and cosmetic dermatology, since 2007. Research and development are the primary objective of Marllor Biomedichal. The major investments are focused on clinical studies, quality and device registration.

Marllor Biomedichal is launching new products by integrating regulatory issues into all of its R&D activities from start to finish. The company has the total exclusive sale of Aqualyx®, the only device in the world indicated for the treatment of localized adiposity.